Skip to main content

Candida Infections News

Germs Love Two Skin 'Hot Spots' on Your Body

MONDAY, Oct. 2, 2023 – Grandma knew it all along: Certain places on the body are "hot spots" for unhealthy microbes. That notion — which the authors of a new study dubbed “the grandma hypothesis,” af...

FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis

SAN DIEGO & PARSIPPANY, N.J.--(BUSINESS WIRE)-- March 22, 2023 – Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced that the U.S. Food and Drug Administration...

FDA Medwatch Alert: Noxafil (posaconazole): Drug Safety Communication - Dosing Errors when Switching between Different Oral Formulations; Label Changes Approved

ISSUE: The FDA is cautioning that differences in dosing regimens between the two oral formulations of the antifungal Noxafil (posaconazole) have resulted in dosing errors.  To help prevent additional ...

FDA Approves Merck’s Noxafil Delayed-Release Tablets

WHITEHOUSE STATION, N.J., Nov. 26, 2013--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

fluconazole, Diflucan